One of the most common things we hear from patients in their late forties and fifties is some version of the same observation.
“Something has changed. My skin feels different. Things I used to do aren’t working anymore. I look tired even when I’m not.”
It is not their imagination. The menopausal transition is one of the most significant biological shifts the skin experiences in a lifetime. And understanding why it happens is the first step toward knowing how to support it.
How does menopause affect collagen?
Menopause is associated with a marked change in skin collagen. Research suggests that dermal collagen may fall by as much as 30% during the first five years after menopause, with further decline in subsequent years. This can contribute to thinner, drier, less elastic skin. Treatments such as JULÄINE™ cannot replace oestrogen or stop this biological process, but collagen biostimulation may form part of a wider strategy for appropriately selected patients who want to support skin quality as they age.
What menopause does to collagen
Oestrogen plays a direct role in collagen production. It stimulates fibroblast activity, supports the skin’s ability to retain moisture, and helps maintain the structural proteins that give skin its firmness and resilience.
During perimenopause and menopause, oestrogen levels decline significantly. Research suggests that dermal collagen may decline by as much as 30% during the first five years after menopause, followed by an average decline of around 2% per year thereafter.
This is not the same gradual decline that happens across adulthood. It is a step change. And many women notice it as exactly that. Not a slow drift, but a shift that feels relatively sudden and disproportionate to their age.
The changes are not just cosmetic. Skin becomes thinner, less elastic, more prone to dryness, and slower to recover from environmental stressors. Facial support reduces. Definition softens. The skin that was maintaining itself reasonably well begins to feel as though it is falling behind.
Why traditional approaches often feel insufficient
Many patients find that approaches which previously felt sufficient no longer seem to address what they are seeing. Skincare may improve hydration and surface quality, while filler can replace volume, but neither necessarily addresses every aspect of the change occurring within the dermal collagen framework.
This reflects a genuine biological reality. When the hormonal environment that supported collagen production is significantly disrupted, the answer is not necessarily more treatment. It is a better understanding of what has changed, and then choosing treatments that address the right layer of the problem.
Sometimes that means skincare. Sometimes collagen stimulation. Sometimes restoring structural support. Often, it is a combination, carefully staged over time.
How JULÄINE™ supports the skin during the menopausal transition
JULÄINE™ is a regenerative collagen biostimulator built using LaSynPro™ technology. These PLLA microspheres stimulate a biological response leading to fibroblast activity and new collagen formation. Rather than adding volume from outside, it is designed to stimulate new collagen formation over time. For appropriately selected patients experiencing menopause-associated changes in skin quality, this gives us a different treatment strategy: rather than simply replacing volume, we can focus on supporting the skin’s underlying collagen framework.
For menopausal patients, this is meaningful because it addresses the underlying biological change rather than masking its surface effects. By stimulating genuine collagen production, JULÄINE™ can support new collagen formation at a time when the skin’s natural collagen framework may be undergoing more rapid change.
The results develop gradually, which suits the way many menopausal patients want to approach their skin. Not dramatic change. Not looking different. Just skin that feels stronger, more resilient, and more like it used to.
For a full explanation of how JULÄINE™ works at a biological level, our guide to what JULÄINE™ is covers the science in depth.
Collagen banking and the menopausal transition
One of the most important concepts for menopausal patients to understand is collagen banking.
The idea is simple. Rather than waiting for collagen loss to become visibly pronounced before treating it, collagen banking involves supporting collagen production proactively, investing in the skin’s structural reserves while it still has the capacity to respond robustly.
For patients in perimenopause, this can be a valuable time to begin thinking proactively about collagen support rather than waiting until changes in skin quality become more established. That is the principle behind collagen banking: not trying to stop ageing, but investing in the quality and resilience of the skin before there is more to correct.
Patients who are already post-menopausal may also be appropriate candidates for collagen-stimulating treatment. Suitability depends on the individual skin, anatomy, medical history and treatment goals rather than menopausal status alone. If you are looking for a broader understanding of how collagen changes across different life stages, our guide to collagen banking through the decades explores this in depth.
What a treatment plan might look like
At Mediject, treatment planning for menopausal patients never begins with a product. It begins with understanding where the skin is, how it has changed, and what it needs.
For many patients, JULÄINE™ forms part of a broader strategy that might also include Ellansé for deeper structural collagen stimulation, medical-grade skincare to support the skin’s surface quality, and lifestyle conversations around the factors that influence collagen health over time. Sun protection, sleep, nutrition, and stress management all play a role in how the skin ages through menopause and beyond. These same factors also influence inflammageing, the chronic low-grade inflammation that accumulates with age and can accelerate collagen breakdown, making lifestyle an important part of any regenerative strategy rather than an afterthought.
Care begins long before the first injection. And for menopausal patients in particular, the consultation is where the most important work happens.
What we see within our Mediject clinic
The menopausal transition is one of the most significant changes I see in my patients’ skin, and one of the areas where I feel the conversation in aesthetics has historically fallen short.
For too long, the response to menopausal skin changes has been to add more. More filler, more product, more treatment. But when the underlying biology has shifted as fundamentally as it does during menopause, adding more to the surface rarely addresses what is actually happening underneath.
What I have found in clinical practice, and what we increasingly understand about the biology of ageing skin, is that the menopausal transition calls for a regenerative response rather than a corrective one. Supporting the skin’s own biology, rebuilding collagen from within, and giving the skin a stronger foundation to age from rather than simply patching the visible signs of a deeper change.
JULÄINE™ has become one of the most important tools in how I approach menopausal skin at Mediject. Not because it solves everything — no single treatment does — but because it addresses the right thing. The biology. The collagen. The structural foundation that oestrogen decline has begun to weaken.
When a patient in perimenopause comes to me and says “something has changed and I don’t know what to do,” this is often where the conversation begins. Not with a treatment plan. With an explanation of what is happening and why. Because understanding it is the first step toward responding to it intelligently.
A quick note on timing
Being postmenopausal does not automatically mean that collagen-stimulating treatment is no longer appropriate. Suitability depends on the individual skin, facial anatomy, medical history and treatment goals, which is why assessment matters more than an arbitrary age cut-off.
The goal is not to categorise patients as early or late. It is to understand where the skin is now and decide whether supporting collagen formation is appropriate at that point in the patient’s life.
Frequently asked questions
Why does skin change so much during menopause?
Oestrogen plays a direct role in collagen production and skin hydration. As oestrogen levels decline during menopause, fibroblast activity reduces, collagen production slows significantly, and the skin becomes thinner, drier, and less structurally supported. Research suggests dermal collagen may decline by as much as 30% during the first five years after menopause.
Can JULÄINE™ help with menopausal skin changes?
For appropriately selected patients, yes. By stimulating fibroblast activity and encouraging new collagen formation, JULÄINE™ may help support the skin’s collagen framework at a time when oestrogen-driven collagen production has reduced. It does not replace oestrogen, but collagen biostimulation can form part of a wider strategy for skin quality and structure.
When is the best time to start JULÄINE™ during the menopause transition?
There is no single best age to start. For some women, perimenopause is an appropriate time to begin taking a more proactive approach to skin quality and collagen support. Postmenopausal patients may also be suitable. The decision should be based on the condition of the skin and the patient’s goals rather than menopausal status alone. This is why a consultation is so important.
Is JULÄINE™ the only treatment that helps menopausal skin?
No. At Mediject, JULÄINE™ often forms part of a wider strategy that may include Ellansé, medical-grade skincare, and lifestyle support. The most effective approach addresses the biology from multiple angles rather than relying on a single treatment.
How long do JULÄINE™ results last for menopausal patients?
JULÄINE™ is designed to produce gradual, longer-term change rather than a short-lived volumising effect. How long results remain visible varies between patients, and maintenance is planned according to the individual’s skin, response and treatment goals. For more detail on what influences longevity, our guide to how long JULÄINE™ lasts covers this thoroughly.
Menopause changes the skin in ways that go beyond what most surface treatments can address. Understanding that change, and responding to it with a genuinely regenerative approach, is what makes the difference between chasing the symptoms and actually supporting the biology.
At Mediject, every recommendation for menopausal patients begins with that understanding. Not a product. Not a protocol. A proper conversation about where your skin is, where it is going, and how we can help it age as well as possible.
Because the goal has never been to look like you did at thirty. It is to continue looking like yourself, feeling well, and recognising the person in the mirror for years to come.
